The company has also raised doubts about the quality of compounded drugs, which are not reviewed premarket by the FDA
And my answer is going to circle back to what you asked me before about the disease of obesity
Mori H, Yoshimi N, Iwata H, Mori Y, Hara A, Tanaka T, Kawai K (1990) Carcinogenicity of naturally occurring 1-hydroxyanthraquinone in rats: induction of large bowel, liver and stomach neoplasms
Understanding Tirzepatide's Mechanism in Diabetes Treatment The innovative approach of this synthetic peptide lies in its dual-action mechanism, as unlike conventional GLP-1 receptor agonists, tirzepatide simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a synergistic effect that enhances glucose-dependent insulin secretion while suppressing inappropriate glucagon release
Acknowledgements We thank the trial volunteers for their dedication and commitment to the study protocol